The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 137 participants.
Also called NCT06649773
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 137 participants
- Registry
-
NCT06649773
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06649773. Randomized; quadruple masking; primary purpose treatment. Start 2024-11-06 (actual); primary completion 2025-05-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Noiiglutide Injection
- Intervention (Drug)
- Noiiglutide Placebo
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06649773- Content hash
3a9471d69f43643d6b6d58c70b2084149b343ac1b1d487a91bfd709c7282428f